Pneumococcal 13-valent conjugate vaccine and Utibron Neohaler

• Generic Name: pneumococcal 13-valent vaccine
• Dosage Forms: n.a.
• Other Brand Names: Prevnar 13

Pneumococcal disease is a serious infection caused by a bacteria. Pneumococcal bacteria can infect the sinuses and inner ear. It can also infect the lungs, blood, and brain, and these conditions can be fatal.

Pneumococcal 13-valent vaccine is used to prevent infection caused by pneumococcal bacteria. This vaccine contains 13 different types of pneumococcal bacteria.

Pneumococcal 13-valent vaccine works by exposing you to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Pneumococcal 13-valent vaccine is for use in children from 6 weeks to 5 years old, and in adults who are 50 and older.

Becoming infected with pneumococcal disease (such as pneumonia or meningitis) is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.

Like any vaccine, pneumococcal 13-valent vaccine may not provide protection from disease in every person.

• Generic Name: glycopyrrolate / indacaterol
• Dosage Forms: inhalation capsule
• Other Brand Names: Utibron Neohaler

Utibron inhalation powder contains a combination of glycopyrrolate and indacaterol. Glycopyrrolate is an anticholinergic. Indacaterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing.

Utibron Neohaler is used long term to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease).

Utibron Neohaler is not for use in treating asthma.

Indacaterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risk.